Reprinted article "The fate of the claudicant--a prospective study of 1969 claudicants"

J A Dormandy1, G D Murray

  • 1St George's Hospital, London SW17, UK.

Insights

This study on intermittent claudication found that age, prior heart disease, and low ankle/arm pressure predict mortality. White blood cell count also indicated risk for heart attack and stroke.

Area of Science:

  • Vascular Medicine
  • Cardiovascular Epidemiology
  • Clinical Trial Analysis

Background:

  • Intermittent claudication (IC) is a common manifestation of peripheral artery disease (PAD).
  • Understanding predictors of cardiovascular events in IC patients is crucial for risk stratification and management.

Purpose of the Study:

  • To identify predictors of serious cardiovascular events and mortality in patients with intermittent claudication.
  • To evaluate the prognostic value of baseline characteristics and laboratory measurements.

Main Methods:

  • Prospective study of 1969 patients with intermittent claudication.
  • Patients received placebo medication for at least 1 year with close monitoring.
  • Analysis of entry characteristics and laboratory data for prediction of cardiovascular events.

Main Results:

  • Annual mortality rate was 4.3%.
  • Significant predictors of total mortality included advanced age, history of coronary heart disease, and ankle/arm pressure ratio < 0.5.
  • Elevated initial white cell count predicted myocardial infarction, stroke, and vascular deaths.

Conclusions:

  • Baseline patient characteristics are strong predictors of adverse cardiovascular outcomes in intermittent claudication.
  • White blood cell count is a significant, yet often overlooked, laboratory marker for vascular risk in this population.